GMP -Regulatory Perspective Sukanti Borkar Abbott India Ltd.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Geoffrey Levitt Chief Counsel, Regulatory and Research Building a Culture of Compliance and Risk Management August 26, 2005.
Biopharmaceutical Quality
The New GMP Annex 11 and Chapter 4 Deadline for coming into operation: 30 June 2011.
Chemistry, Manufacturing, and Controls (CMC) and Good Manufacturing Practices (GMPs): The Big Picture of a Long-term Commitment Elizabeth Pollina Cormier,
INSAG DEVELOPMENT OF A DOCUMENT ON HIGH LEVEL SAFETY RECOMMENDATIONS FOR NUCLEAR POWER Milestone Issues: Group C. Nuclear Safety. A. Alonso (INSAG Member)
Overview Lesson 10,11 - Software Quality Assurance
Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science July 20-21, 2004 Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical.
Pilot Risk-Ranking Model to Prioritize Manufacturing Sites for GMP Inspections Advisory Committee for Pharmaceutical Science Manufacturing Subcommittee.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Good Manufacturing Practices for Blood Establishments
Regulatory requirements and benefits converting to Continued Process Verification.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
WHO FOOD COURSE SAFE FOOD PRODUCTION: HACCP HACCP and food regulators.
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
World Health Organization
Global Quality Operations Sustaining Quality ^ : Why is Quality Good for Business? Diane E. Bergeron Vice President Global Quality Operations Schering-Plough.
Ship Recycling Facility Management System IMO Guideline A.962
© 2011 Michigan State University and United Nations Industrial Development Organization, original at CC-BY-SA Procedures FSKN.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
World Health Organization
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
© 2011 Underwriters Laboratories Inc. All rights reserved. This document may not be reproduced or distributed without authorization. ASSET Safety Management.
IT Requirements Management Balancing Needs and Expectations.
1 PAT and Biological Products Tom Layloff FDA-SGE Management Sciences for Health The views expressed here are those of the author and not necessarily.
Important informations
Developing the competency of managers in the field of safety management Aidan Nelson Director Policy & Standards International Railway Safety Conference.
Energy Efficiency and Emission Management Edwin van den Maagdenberg Vice President Technology and Operations Honeywell Process Solutions.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Quality Management.
Part 11, Electronic Records; Electronic Signatures
UNIDO - Energy Efficiency Creating a Standard Framework for Sustainable Industrial Energy Efficiency Lorence Ansermet UNIDO Regional Office in South Africa.
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Risk-Based CMC Review - OGD Perspective Gary J. Buehler, R.Ph. Director Office of Generic Drugs July 21, 2004 Advisory Committee for Pharmaceutical Science.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
Good Manufacturing Practices – A Regulatory Perspective Presented By: Ashok Kumar Dua Plant Head – Unichem Laboratories (Sikkim )
Drug Quality Regulations for the 21 st Century PhRMA Perspective Manufacturing Subcommittee Meeting – May 21, 2003 Gerry Migliaccio Pfizer Inc.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
GMP AND cGMP CONSIDERATIONS
CM&C Inspections The Pre-Approval Inspection (PAI) in the US 27 May 2010.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
© 2009 Michigan State University licensed under CC-BY-SA, original at Incident Management.
© 2011 Michigan State University and United Nations Industrial Development Organization, original at CC-BY-SA Suppliers Performance.
KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.
© 2016 Chapter 6 Data Management Health Information Management Technology: An Applied Approach.
Director Policy & Standards International Railway Safety Conference
Food Product Development
Pharmaceutical Quality Control & current Good Manufacturing Practice
An Update on ICH Guideline – Pharmaceutical Development
Developing the Overall Audit Plan and Audit Program
QUALITY ASSURANCE AND QUALITY CONTROL IN GENERICS
Quality Metrics for better Quality Compliance
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Quality Assurance and Quality Control in Generics
Data Managers’ Forum What’s in it for us?
Food Production Systems
Quality System.
Introduction to GMP.
Air Carrier Continuing Analysis and Surveillance System (CASS)
MDIC- Case for Quality Forum
BU IS GIG Chemical, Oil & Gas
Combination products The paradigm shift
BPT 2423 – STATISTICAL PROCESS CONTROL
Leadership and Management for Safety
ICH Q9: Quality Risk Management
ICH Q9: Quality Risk Management
Computer System Validation
Storage and distribution
Presentation transcript:

GMP -Regulatory Perspective Sukanti Borkar Abbott India Ltd.

Content Quality Culture today Challenges for Quality Future of Quality

Quality Culture today Regulatory compliance is becoming increasingly complex and the power and reach of key regulators is ever widening…. In current scenario, there is a shift in regulator approach, where agencies representatives were more practical and concerned about the product quality throughout the product lifecycle but now it is more than this………..

Quality Culture today.. Pharmaceutical manufacturing HIGHLY regulated compared to food, chemical, etc Cost of cGMP compliance very high Reasons for manufacturing /testing failures sometimes not understood The service providers to Formulation industry such as API manufacturers, etc need to be equally regulated Industry opting for additional systems such as Six Sigma, Lean,etc. sometimes clashing up with methodologies.

Expectations for Quality Are safe Are efficacious Have the correct identity Deliver the same performance as described in the label Perform consistently over their shelf life Are made in a manner that ensures quality Will be available when needed

Quality Risk Management Prime Focus Areas Quality By Design Quality Risk Management Data Integrity

Quality By Design Quality by Design (QbD) is a concept first outlined by quality expert Joseph M. Juran Benefits of QbD Improvement in Product Quality and Product Robustness/ Reproducibility • Improved Development Capability, Speed and Formulation Design • Cost Reduction Benefits • Yield Increase • Fast and Reliably to Market • Increased Process Capability; Reduced Atypicals • Reduced Impact of Raw Material Variability • Improved Product Stability • Improved Scale Up Efficiency/Speed

Quality Risk Management Risk: Combination of the probability of occurrence of harm and severity of the harm. Goal is to reduce patient risk Quality risk management can apply to various quality system but not limited to: Management Review Corrective and Preventative system Complaints Product Action Validation/Qualification

Data Integrity Data integrity refers to maintaining and assuring the accuracy and consistency of data over its entire life-cycle. The main criteria for data integrity are listed below Accurate - No errors or Editing without documented amendments. Attributable - Who acquired the data or performed an action and when. Available - For review and audit or inspection over the lifetime of the record. Complete - All data are present and available. Contemporaneous - Documented at the time of the activity. Enduring - On proven storage media (paper or electronic). Legible - Data can be easily read. Original / Reliable - Written printout or observation or a certified copy thereof. Trustworthy - Data and the record have not been tampered

Challenges for Quality Little incentive to upgrade facilities, processes, or knowledge to existing approved products - Perceived as low return on investment Market does not reward quality Perceived low enforcement threat Complexity of handling changes for multiple markets Fear of discovering a previously unknown issue

Challenges for Quality Lack of “Quality Culture” Manufacturing objectives targeted to meet market requirements, versus meeting compliance / patient expectations Can lead to short sighted decision making People are not designed for perfection! Even really good people make mistakes! EVERY error has multiple causes and associated contributing factors Circumstances and the working environment have a profound impact

Future of Quality Commitment to quality, including: – Establishing effective pharmaceutical quality systems Invest in quality and continual improvement – Quality can pay for itself!

Future of Quality An environment where each and every person understands and embraces their responsibility for protecting product quality and patient safety

Simple fact of Life….. Blame culture Over complexity We can’t significantly alter people’s behaviour but we can DRAMATICALLY influence their working conditions So improve on- Blame culture Over complexity Financially driven performance measures Poor education and training Focus on cost not quality Poor change control Repeat deviations Lack of process robustness Disconnected, invisible leadership Ineffective audits Demotivation

Thank You Make GMP a lifestyle!!!